Lena V Gast, Teresa Gerhalter, Matthias Türk, Alper Sapli, Claudius S Mathy, Rafael Heiss, Pierre-Yves Baudin, Benjamin Marty, Michael Uder, Armin M Nagel
{"title":"7 T时钾(39K)钠(23Na)联合MRI测定营养不良骨骼肌组织钾、钠浓度","authors":"Lena V Gast, Teresa Gerhalter, Matthias Türk, Alper Sapli, Claudius S Mathy, Rafael Heiss, Pierre-Yves Baudin, Benjamin Marty, Michael Uder, Armin M Nagel","doi":"10.1002/nbm.70009","DOIUrl":null,"url":null,"abstract":"<p><p>Combined <sup>23</sup>Na/<sup>39</sup>K MRI at 7 T can highlight ion disturbances in skeletal muscle tissue. In this work, we investigated if the apparent tissue potassium concentration (aTPC) can be determined in fatty replaced muscles of patients with facio-scapulo-humeral muscular dystrophy (FSHD) and if it can provide additional information to the fat replacement and the apparent tissue sodium concentration (aTSC). The lower leg of 14 patients (six females, eight males; mean age 47.7 ± 14.0 years) with genetically confirmed FSHD and 11 healthy controls (four females, seven males; mean age 47.0 ± 14.0 years) was examined at a 7-T MR system using a dual-tuned <sup>23</sup>Na/<sup>39</sup>K birdcage RF coil. In addition, qualitative and quantitative <sup>1</sup>H MR measurements were performed at 7 T to assess the fat replacement and water accumulation. The aTPC and aTSC were determined in seven different muscle regions based on five external references phantoms and corrected for partial volume effects, relaxation biases, and reduced ion concentrations in fat. Results are expressed as median (interquartile range). The measured aTPC was strongly reduced in fat-replaced muscles and was close to zero in totally fat replaced muscles (aTPC = 4.3 mM [2.7 mM] for FF > 80%). After correction of aTPC values for reduced potassium concentration in fat, aTPC<sub>fc</sub> values of patients in muscles with low or moderate fat fraction (FF < 30%) were similar to values of healthy subjects (patients: aTPC<sub>fc</sub> = 85.6 mM [21.7 mM]; controls: aTPC<sub>fc</sub> = 83.2 mM [22.3 mM]). However, muscles with FF > 30% showed reduced aTPC<sub>fc</sub> and increased aTSC<sub>fc</sub> compared with healthy controls (aTPC<sub>fc</sub> = 28.9 mM [46.2 mM], aTSC<sub>fc</sub> = 42.3 mM [17.6 mM]; controls: aTSC<sub>fc</sub> = 15.0 mM [4.6 mM], aTPC<sub>fc</sub> = 83.2 mM [22.3 mM]). No correlations were observed between the aTPC<sub>fc</sub> and aTSC<sub>fc,</sub> or between aTPC<sub>fc</sub> and water T<sub>2</sub>. We showed that a determination of the aTPC in dystrophic skeletal muscles is feasible using <sup>39</sup>K MRI at 7 T. Measured changes in aTPC<sub>fc</sub> were greater than sole fat replacement and might therefore be used as an additional quantitative measure for dystrophic muscle tissue.</p>","PeriodicalId":19309,"journal":{"name":"NMR in Biomedicine","volume":"38 4","pages":"e70009"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833145/pdf/","citationCount":"0","resultStr":"{\"title\":\"Determination of Tissue Potassium and Sodium Concentrations in Dystrophic Skeletal Muscle Tissue Using Combined Potassium (<sup>39</sup>K) and Sodium (<sup>23</sup>Na) MRI at 7 T.\",\"authors\":\"Lena V Gast, Teresa Gerhalter, Matthias Türk, Alper Sapli, Claudius S Mathy, Rafael Heiss, Pierre-Yves Baudin, Benjamin Marty, Michael Uder, Armin M Nagel\",\"doi\":\"10.1002/nbm.70009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Combined <sup>23</sup>Na/<sup>39</sup>K MRI at 7 T can highlight ion disturbances in skeletal muscle tissue. In this work, we investigated if the apparent tissue potassium concentration (aTPC) can be determined in fatty replaced muscles of patients with facio-scapulo-humeral muscular dystrophy (FSHD) and if it can provide additional information to the fat replacement and the apparent tissue sodium concentration (aTSC). The lower leg of 14 patients (six females, eight males; mean age 47.7 ± 14.0 years) with genetically confirmed FSHD and 11 healthy controls (four females, seven males; mean age 47.0 ± 14.0 years) was examined at a 7-T MR system using a dual-tuned <sup>23</sup>Na/<sup>39</sup>K birdcage RF coil. In addition, qualitative and quantitative <sup>1</sup>H MR measurements were performed at 7 T to assess the fat replacement and water accumulation. The aTPC and aTSC were determined in seven different muscle regions based on five external references phantoms and corrected for partial volume effects, relaxation biases, and reduced ion concentrations in fat. Results are expressed as median (interquartile range). The measured aTPC was strongly reduced in fat-replaced muscles and was close to zero in totally fat replaced muscles (aTPC = 4.3 mM [2.7 mM] for FF > 80%). After correction of aTPC values for reduced potassium concentration in fat, aTPC<sub>fc</sub> values of patients in muscles with low or moderate fat fraction (FF < 30%) were similar to values of healthy subjects (patients: aTPC<sub>fc</sub> = 85.6 mM [21.7 mM]; controls: aTPC<sub>fc</sub> = 83.2 mM [22.3 mM]). However, muscles with FF > 30% showed reduced aTPC<sub>fc</sub> and increased aTSC<sub>fc</sub> compared with healthy controls (aTPC<sub>fc</sub> = 28.9 mM [46.2 mM], aTSC<sub>fc</sub> = 42.3 mM [17.6 mM]; controls: aTSC<sub>fc</sub> = 15.0 mM [4.6 mM], aTPC<sub>fc</sub> = 83.2 mM [22.3 mM]). No correlations were observed between the aTPC<sub>fc</sub> and aTSC<sub>fc,</sub> or between aTPC<sub>fc</sub> and water T<sub>2</sub>. We showed that a determination of the aTPC in dystrophic skeletal muscles is feasible using <sup>39</sup>K MRI at 7 T. Measured changes in aTPC<sub>fc</sub> were greater than sole fat replacement and might therefore be used as an additional quantitative measure for dystrophic muscle tissue.</p>\",\"PeriodicalId\":19309,\"journal\":{\"name\":\"NMR in Biomedicine\",\"volume\":\"38 4\",\"pages\":\"e70009\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833145/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NMR in Biomedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/nbm.70009\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOPHYSICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NMR in Biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/nbm.70009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
摘要
7 T时23Na/39K联合MRI可以突出骨骼肌组织中的离子干扰。在这项工作中,我们研究了是否可以在面部-肩胛-肱骨肌营养不良(FSHD)患者的脂肪替代肌肉中测定表观组织钾浓度(aTPC),以及它是否可以为脂肪替代和表观组织钠浓度(aTSC)提供额外的信息。下肢14例(女6例,男8例;平均年龄47.7±14.0岁),遗传确诊为FSHD,健康对照11例(女性4例,男性7例;平均年龄47.0±14.0岁),采用双调谐23Na/39K鸟笼式射频线圈,在7-T MR系统中进行检查。此外,在7 T时进行定性和定量1H MR测量,以评估脂肪替代和水分积累。aTPC和aTSC在7个不同的肌肉区域根据5个外部参考图进行测定,并校正了部分体积效应、松弛偏差和脂肪中离子浓度的降低。结果以中位数(四分位数范围)表示。在脂肪替代肌肉中,测量到的aTPC显著降低,在完全脂肪替代肌肉中,aTPC接近于零(FF > 80%时,aTPC = 4.3 mM [2.7 mM])。在对脂肪中钾浓度降低的aTPC值进行校正后,低脂肪或中等脂肪比例肌肉患者的aTPCfc值(FF fc = 85.6 mM [21.7 mM];对照组:aTPCfc = 83.2 mM [22.3 mM])。然而,与健康对照组相比,FF bb0 30%的肌肉显示aTPCfc减少,aTSCfc增加(aTPCfc = 28.9 mM [46.2 mM], aTSCfc = 42.3 mM [17.6 mM];控制:aTSCfc = 15.0毫米(4.6毫米),aTPCfc = 83.2毫米(22.3毫米))。aTPCfc和aTSCfc之间没有相关性,aTPCfc和水T2之间也没有相关性。我们表明,在7 T时使用39K MRI测定营养不良骨骼肌的aTPC是可行的。测量到的aTPCfc变化大于单一脂肪替代,因此可以用作营养不良肌肉组织的额外定量测量。
Determination of Tissue Potassium and Sodium Concentrations in Dystrophic Skeletal Muscle Tissue Using Combined Potassium (39K) and Sodium (23Na) MRI at 7 T.
Combined 23Na/39K MRI at 7 T can highlight ion disturbances in skeletal muscle tissue. In this work, we investigated if the apparent tissue potassium concentration (aTPC) can be determined in fatty replaced muscles of patients with facio-scapulo-humeral muscular dystrophy (FSHD) and if it can provide additional information to the fat replacement and the apparent tissue sodium concentration (aTSC). The lower leg of 14 patients (six females, eight males; mean age 47.7 ± 14.0 years) with genetically confirmed FSHD and 11 healthy controls (four females, seven males; mean age 47.0 ± 14.0 years) was examined at a 7-T MR system using a dual-tuned 23Na/39K birdcage RF coil. In addition, qualitative and quantitative 1H MR measurements were performed at 7 T to assess the fat replacement and water accumulation. The aTPC and aTSC were determined in seven different muscle regions based on five external references phantoms and corrected for partial volume effects, relaxation biases, and reduced ion concentrations in fat. Results are expressed as median (interquartile range). The measured aTPC was strongly reduced in fat-replaced muscles and was close to zero in totally fat replaced muscles (aTPC = 4.3 mM [2.7 mM] for FF > 80%). After correction of aTPC values for reduced potassium concentration in fat, aTPCfc values of patients in muscles with low or moderate fat fraction (FF < 30%) were similar to values of healthy subjects (patients: aTPCfc = 85.6 mM [21.7 mM]; controls: aTPCfc = 83.2 mM [22.3 mM]). However, muscles with FF > 30% showed reduced aTPCfc and increased aTSCfc compared with healthy controls (aTPCfc = 28.9 mM [46.2 mM], aTSCfc = 42.3 mM [17.6 mM]; controls: aTSCfc = 15.0 mM [4.6 mM], aTPCfc = 83.2 mM [22.3 mM]). No correlations were observed between the aTPCfc and aTSCfc, or between aTPCfc and water T2. We showed that a determination of the aTPC in dystrophic skeletal muscles is feasible using 39K MRI at 7 T. Measured changes in aTPCfc were greater than sole fat replacement and might therefore be used as an additional quantitative measure for dystrophic muscle tissue.
期刊介绍:
NMR in Biomedicine is a journal devoted to the publication of original full-length papers, rapid communications and review articles describing the development of magnetic resonance spectroscopy or imaging methods or their use to investigate physiological, biochemical, biophysical or medical problems. Topics for submitted papers should be in one of the following general categories: (a) development of methods and instrumentation for MR of biological systems; (b) studies of normal or diseased organs, tissues or cells; (c) diagnosis or treatment of disease. Reports may cover work on patients or healthy human subjects, in vivo animal experiments, studies of isolated organs or cultured cells, analysis of tissue extracts, NMR theory, experimental techniques, or instrumentation.